BioSpace News Archive

emocha Health, the leading digital medication adherence platform that serves over 450 public health departments nationwide, has worked with Alameda County, California’s Tuberculosis program to support its patients since 2017.

AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, today announced a $125 million crossover financing.

CanaQuest Targeting Same Mental Health Space Where GW Pharma was Acquired for US$7.2B

Dr. Denis Bedoret, chief executive officer at Imcyse, and Andrew Knudten, chief operating officer at Jaguar Gene Therapy, join Kiniciti Advisory Board.

ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, announced mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an ABEC 4,000L CSR Bioreactor.

The psychedelics industry requires a standardized reference data set to identify and develop medicines with enhanced therapeutic benefit and improved safety and pharmacological profiles.

Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often complicated by arrhythmias, a condition where the heart beats too rapidly, too slowly or irregularly due to a misfiring of the body’s electrical impulses.

Hijack RNA™ Treatment Strategy Shows Successful Results After Preclinical Trials Using SARS-CoV-2’s Own Key Protein Enzymes to Inactivate and Kill The Virus Within 48 Hours

Management of each of Mindset and InterVivo believe that the psychedelic pharma industry will benefit greatly from a standardized reference data set to identify and develop medicines with enhanced therapeutic benefit and improved safety and pharmacological profiles.

Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced it will host an expert perspectives panel on the evolving treatment landscape for idiopathic pulmonary fibrosis (IPF) and the potential for GB0139 on Tuesday, March 30, 2021 at 2pm Eastern Time.